Icteric toxic hepatitis associated with riluzole

Lancet

Volumn 351, Issue 9103, 1998, Pages 648-

  Castells, Ll ^a   Gamez J ^b   Cervera, C ^b   Guardia, J ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RILUZOLE;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CASE REPORT; FEMALE; HUMAN; PRIORITY JOURNAL; TOXIC HEPATITIS;

EID: 0032574290     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)78431-2     Document Type: Article

References (3)

1. 1 Miller RG, Sufit R. New approaches to the treatment of ALS. Neurology 1997; 48 (suppl 4): S28-32.
2. 2 Bensimon G, Lacomblez L, Meininger V, and the ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994; 330: 585-91.
3. 3 Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meiniger V, for the Amyotrophic Lateral Sclerosis/Riluzole Group II. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 1996; 347: 1425-31.